PFE, Pfizer

What To Expect From PFE Stock In 2025?
In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 could turn out.
Here's Why Pfizer (PFE) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is Pfizer Inc. (PFE) the Best Stock to Invest In For Steady Dividends?
We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks.
Is Pfizer Stock a Buy?
The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.
Jefferies Keeps Their Buy Rating on Pfizer (PFE)
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares
Pfizer Inc. stock outperforms competitors on strong trading day
Pfizer Inc. closed 16.17% below its 52-week high of $31.54, which the company achieved on July 30th.
Pfizer Inc (PFE) Stock: A Deeper Look at Its True Potential
Pfizer Inc (PFE) stock saw a decline, ending the day at $26.3 which represents a decrease of $-0.19 or -0.72% from the prior close of $26.49. The stock opened at $26.4 and touched a low of $26.22 during the day,
Bernstein Sticks to Their Hold Rating for Pfizer (PFE)
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $32.00. The
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...
Can This Beaten-Down Stock Bounce Back in 2025?
In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales ...
bovnews13d
How Does Pfizer Inc (PFE) Stack Up Against Its Industry Peers?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...
Why Is Prem Watsa Bullish On Pfizer Inc. (PFE) Now?
We recently compiled a list of the Billionaire Prem Watsa’s Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against Prem Watsa’s other ...
Pfizer Unusual Options Activity For January 21
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Ritholtz Wealth Management
Ritholtz Wealth Management decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 39.4% during the 4th ...